Gateway Advisory’s Celgene Corp CELG Stock Holding History

Gateway Advisory’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,720	Closed	-$1.43M	–	104
2017 Q4	$1.43M	Buy	+13,720	New	+$1.55M	0.4%	42
2015 Q3	–	Sell	-8,000	Closed	-$926K	–	47
2015 Q2	$926K	Buy	+8,000	New	+$915K	0.41%	27
2015 Q1	–	Sell	-8,000	Closed	-$895K	–	44
2014 Q4	$895K	Buy	+8,000	New	+$844K	0.4%	25
2014 Q3	–	Sell	-8,600	Closed	-$739K	–	43
2014 Q2	$739K	Buy	+8,600	New	+$654K	0.34%	29

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Gateway Advisory's CELG Position: Q1 2018 in Review

Gateway Advisory sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 13,720 shares — an estimated $1.43M sold.

Gateway Advisory first reported a position in CELG in Q2 2014 and held it in 4 quarters. The position peaked at $1.43M in Q4 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Gateway Advisory reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Gateway Advisory sold 13,720 Celgene Corp shares in Q1 2018, an estimated $1.43M.
Gateway Advisory first reported a position in Celgene Corp in Q2 2014 and held it in 4 quarters.
Gateway Advisory's Celgene Corp position peaked at $1.43M in Q4 2017.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Gateway Advisory's 13F filing for Q1 2018, filed 20 Apr 2018.